Tripterygium wilfordii Polyglycoside Ameliorated TNBS-Induced Colitis in Rats via Regulating Th17/Treg Balance in Intestinal Mucosa
Cui Zhang,Jingyi Ju,Xiaohan Wu,Jiaolan Yang,Qinglu Yang,Changqin Liu,Liang Chen,Xiaomin Sun
DOI: https://doi.org/10.2147/JIR.S293961
IF: 4.5
2021-04-01
Journal of Inflammation Research
Abstract:Cui Zhang, 1 Jingyi Ju, 1 Xiaohan Wu, 1 Jiaolan Yang, 1 Qinglu Yang, 1 Changqin Liu, 1 Liang Chen, 1 Xiaomin Sun 1, 2 1 Gastroenterology Department, The Shanghai Tenth People's Hospital, Tongji University, Shanghai, People's Republic of China; 2 Gastroenterology Department, The Shanghai Tenth People's Hospital, Chongming Branch, Shanghai, People's Republic of China Correspondence: Xiaomin Sun The Shanghai Tenth People's Hospital, Tongji University, Yanchang Middle Road No. 301, Shanghai, People's Republic of China Tel +86 021 6630 1164 Email Purpose: To investigate the therapeutic effect of Tripterygium wilfordii polyglycoside (TWP), a derivative from a Chinese traditional herb, on 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis, in a model for inflammatory bowel disease (IBD) in rats. Methods: TWP was administrated to Wistar rats during TNBS-induced colitis to determine its therapeutic effect on active inflammation using the Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR), flow cytometry, and Western blotting. Peripheral blood CD4 + T-cells were isolated from patients with ulcerative colitis (UC) and incubated with TWP to verify its immune regulation mechanism by qRT-PCR and flow cytometry. Results: Intragastric administration of TWP attenuated the severity of intestinal inflammation in TNBS-induced rat colitis, characterized by decreased DAI, histopathological scores, and expression of IL-6, TNFα, IFNγ, and IL-17A in intestinal mucosa. Furthermore, TWP reduced IL-17A + CD4 + T-cells, while enhanced Foxp3 + CD25 + CD4 + T-cells in peripheral blood, mesenteric lymph nodes (MLN), and spleen in rat colitis. Downstream signaling including ROR-γt, STAT3, and HIF1α expression in intestinal mucosa were suppressed by TWP. In addition, incubation with TWP suppressed IL-17A + CD4 + T-cell differentiation, while it promoted Foxp3 + CD25 + CD4 + T-cell differentiation in CD4 + T-cells isolated from UC patients. Conclusion: TWP successfully ameliorated experimental rat colitis via regulating innate immune responses as well as Th17/Treg balance in intestinal mucosa, peripheral blood, MLN, and spleen. Moreover, the differentiation of peripheral blood CD4 + T-cell isolated from patients with UC was modulated by TWP. TWP may act as an optional complementary and alternative medicine for IBD. Keywords: inflammatory bowel disease, Tripterygium wilfordii polyglycoside, intestinal mucosa immunity, T helper 17 cell, regulatory T-cell
immunology